Tactical damage control resuscitation in austere military environments

Journal of the Royal Army Medical Corps

Volumn 162, Issue 6, 2016, Pages 419-427

  Daniel, Yann ^a   Habas, S ^a   Malan, L ^a   Escarment, J ^b,c   David, J S ^d,e   Peyrefitte, S ^a  

^a Antenne médicale spécialisée de Lorient Lanester   (France)

^b HIA Desgenettes   (France)

^c Dir Reg du Serv de S des Armees   (France)

^d EDOUARD HERRIOT HOSPITAL   (France)

^e UNIVERSITÉ LYON 1   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFIBRINOLYTIC AGENT; BLOOD CLOTTING FACTOR; COAGULATING AGENT; FIBRINOGEN; PROTHROMBIN COMPLEX CONCENTRATES; TRANEXAMIC ACID;

BLOOD COAGULATION DISORDERS; BLOOD COMPONENT THERAPY; BLOOD TRANSFUSION; COMPLICATION; FREEZE DRYING; HEMORRHAGE; HUMAN; MILITARY MEDICINE; PLASMA; POINT OF CARE TESTING; PROCEDURES; RESUSCITATION; SHOCK, HEMORRHAGIC; SOLDIER; WOUNDS AND INJURIES;

ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION DISORDERS; BLOOD COAGULATION FACTORS; BLOOD COMPONENT TRANSFUSION; BLOOD TRANSFUSION; COAGULANTS; FIBRINOGEN; FREEZE DRYING; HEMORRHAGE; HUMANS; MILITARY MEDICINE; MILITARY PERSONNEL; PLASMA; POINT-OF-CARE TESTING; RESUSCITATION; SHOCK, HEMORRHAGIC; TRANEXAMIC ACID; WOUNDS AND INJURIES;

EID: 84998579477     PISSN: 00358665     EISSN: None     Source Type: Journal    
DOI: 10.1136/jramc-2016-000628     Document Type: Article

References (121)

1. Butler FKJ, Blackbourne LH. Battlefield trauma care then and now: a decade of Tactical Combat Casualty Care. J Trauma Acute Care Surg 2012; 73: S395-402.
2. Blackbourne LH, Baer DG, Eastridge BJ, et al. Military medical revolution: prehospital combat casualty care. J Trauma Acute Care Surg 2012; 73: S372-7.
3. Eastridge BJ, Mabry RL, Seguin P, et al. Death on the battlefield (2001-2011): implications for the future of combat casualty care. J Trauma Acute Care Surg 2012; 73: S431-7.
4. Service de Santé des Armées, Ecole du Val-de-Grâce. Enseignement du Sauvetage au Combat. Référentiel de formation No 0309/EVDG/DPMO du 30 mars, 2012. 37p. Disponible en ligne sur internet: http://sofia.medicalistes.org/spip/IMG/pdf/ Enseignement_du_Sauvetage_au_Combat_Referentiel_de_formation_janvier_2012_pdf
5. Bennett BL, Littlejohn LF, Kheirabadi BS, et al. Management of external hemorrhage in tactical combat casualty care: Chitosan-based hemostatic gauze dressings-TCCC Guidelines-Change 13-05. J Spec Oper Med 2014; 14: 40-57.
6. Fries CA, Midwinter MJ. Trauma resuscitation and damage control surgery. Surgery (Oxford) 2010; 28: 563-7.
7. NATO standardization agency (NSA), AJP-4.10(A) Allied joint medical support doctrine. 2006. http://www.aco.nato.int/medical-support/publications.aspx
8. Mikhail J. The trauma triad of death: hypothermia, acidosis, and coagulopathy. AACN Clin Issues 1999; 10: 85-94.
9. Pohlman TH, Walsh M, Aversa J, et al. Damage control resuscitation. Blood Rev 2015; 29: 251-62.
10. David JS, Roumagnac A, Rulliat É, et al. [Diagnosis and treatment of trauma-induced coagulopathy]. Transfus Clin Biol 2012; 19: 165-73.
11. Dénécé E, Warney N. La France et les opérations spéciales. Stratégique 1996; 61. http://www.institut-strategie.fr/strat_061_DENECE.html (accessed 26 July 2016).
12. Wallace GR. NATO SOF Transformation and the development of NATO SOF medical doctrine and policy. J Spec Oper Med 2009; 9: 7-13.
13. Mucciarone JJ, Llewellyn CH, Wightman JM. Tactical combat casualty care in the assault on Punta Paitilla Airfield. Mil Med 2006; 171: 687-90.
14. Mabry RL, Holcomb JB, Baker AM, et al. United States Army Rangers in Somalia: an analysis of combat casualties on an urban battlefield. J Trauma 2000; 49: 515-28; discussion 528.
15. Kotwal RS, Montgomery HR, Kotwal BM, et al. Eliminating preventable death on the battlefield. Arch Surg 2011; 146: 1350-8.
16. Holcomb JB, McMullin NR, Pearse L, et al. Causes of death in U.S. Special Operations Forces in the global war on terrorism: 2001-2004. Ann Surg 2007; 245: 986-91.
17. Glassberg E, Nadler R, Gendler S, et al. Freeze-dried plasma at the point of injury: from concept to doctrine. Shock 2013; 40: 444-50.
18. Fisher AD, Miles EA, Cap AP, et al. Tactical damage control resuscitation. Mil Med 2015; 180: 869-75.
19. Brohi K, Singh J, Heron M, et al. Acute traumatic coagulopathy. J Trauma 2003; 54: 1127-30.
20. Rugeri L, Levrat A, David JS, et al. Diagnosis of early coagulation abnormalities in trauma patients by rotation thrombelastography. J Thromb Haemost 2007; 5: 289-95.
21. Simmons JW, White CE, Ritchie JD, et al. Mechanism of injury affects acute coagulopathy of trauma in combat casualties. J Trauma 2011; 71: S74-7.
22. Davenport R, Manson J, De’Ath H, et al. Functional definition and characterization of acute traumatic coagulopathy. Crit Care Med 2011; 39: 2652-8.
23. Brohi K, Cohen MJ, Ganter MT, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma 2008; 64: 1211-17; discussion 1217.
24. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care 2007; 13: 680-5.
25. Watts DD, Trask A, Soeken K, et al. Hypothermic coagulopathy in trauma: effect of varying levels of hypothermia on enzyme speed, platelet function, and fibrinolytic activity. J Trauma 1998; 44: 846-54.
26. Dirkmann D, Hanke AA, Görlinger K, et al. Hypothermia and acidosis synergistically impair coagulation in human whole blood. Anesth Analg 2008; 106: 1627-32.
27. D’Angelo MR, Dutton RP. Management of trauma-induced coagulopathy: trends and practices. AANA J 2010; 78: 35-40.
28. Davenport R, Khan S. Management of major trauma haemorrhage: treatment priorities and controversies. Br J Haematol 2011; 155: 537-48.
29. Burggraf M, Payas A, Kauther MD, et al. Evaluation of clotting factor activities early after severe multiple trauma and their correlation with coagulation tests and clinical data. World J Emerg Surg 2015; 10: 43.
30. Rizoli SB, Scarpelini S, Callum J, et al. Clotting factor deficiency in early trauma-associated coagulopathy. J Trauma 2011; 71: S427-34.
31. Rourke C, Curry N, Khan S, et al. Fibrinogen levels during trauma hemorrhage, response to replacement therapy, and association with patient outcomes. J Thromb Haemost 2012; 10: 1342-51.
32. Tauber H, Innerhofer P, Breitkopf R, et al. Prevalence and impact of abnormal ROTEM(R) assays in severe blunt trauma: results of the ‘Diagnosis and Treatment of Trauma-Induced Coagulopathy (DIA-TRE-TIC) study’. Br J Anaesth 2011; 107: 378-87.
33. Hiippala ST, Myllylä GJ, Vahtera EM. Hemostatic factors and replacement of major blood loss with plasma-poor red cell concentrates. Anesth Analg 1995; 81: 360-5.
34. Floccard B, Rugeri L, Faure A, et al. Early coagulopathy in trauma patients: an on-scene and hospital admission study. Injury 2012; 43: 26-32.
35. Fries D, Martini WZ. Role of fibrinogen in trauma-induced coagulopathy. Br J Anaesth 2010; 105: 116-21.
36. Raza I, Davenport R, Rourke C, et al. The incidence and magnitude of fibrinolytic activation in trauma patients. J Thromb Haemost 2013; 11: 307-14.
37. Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet 2010; 376: 23-32.
38. Roberts I, Shakur H, Afolabi A, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet 2011; 377: 1096-101, 1101.e1-2.
39. de Guzman R, Polykratis IA, Sondeen JL, et al. Stability of tranexamic acid after 12-week storage at temperatures from -20°C to 50°C. Prehosp Emerg Care 2013; 17: 394-400.
40. Porta CR, Nelson D, McVay D, et al. The effects of tranexamic acid and prothrombin complex concentrate on the coagulopathy of trauma: an in vitro analysis of the impact of severe acidosis. J Trauma Acute Care Surg 2013; 75: 954-60.
41. Morrison JJ, Dubose JJ, Rasmussen TE, et al. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg 2012; 147: 113-19.
42. Butler FK, Holcomb JB, Schreiber MA, et al. Fluid resuscitation for hemorrhagic shock in tactical combat casualty care: TCCC guidelines change 14-01-2 June 2014. J Spec Oper Med 2014; 14: 13-38.
43. Gonzalez EA, Moore FA, Holcomb JB, et al. Fresh frozen plasma should be given earlier to patients requiring massive transfusion. J Trauma 2007; 62: 112-19.
44. Teixeira PG, Inaba K, Shulman I, et al. Impact of plasma transfusion in massively transfused trauma patients. J Trauma 2009; 66: 693-7.
45. Holcomb JB, del Junco DJ, Fox EE, et al. The prospective, observational, multicenter, major trauma transfusion (PROMMTT) study: comparative effectiveness of a time-varying treatment with competing risks. JAMA Surg 2013; 148: 127-36.
46. del Junco DJ, Holcomb JB, Fox EE, et al. Resuscitate early with plasma and platelets or balance blood products gradually: findings from the PROMMTT study. J Trauma Acute Care Surg 2013; 75: S24-30.
47. Spinella PC, Perkins JG, Grathwohl KW, et al. Effect of plasma and red blood cell transfusions on survival in patients with combat related traumatic injuries. J Trauma 2008; 64: S69-77; discussion S77.
48. Borgman MA, Spinella PC, Perkins JG, et al. The ratio of blood products transfused affects mortality in patients receiving massive transfusions at a combat support hospital. J Trauma 2007; 63: 805-13.
49. Tapia NM, Suliburk J, Mattox KL. The initial trauma center fluid management of penetrating injury: a systematic review. Clin Orthop Relat Res 2013; 471: 3961-73.
50. Inaba K, Branco BC, Rhee P, et al. Impact of plasma transfusion in trauma patients who do not require massive transfusion. J Am Coll Surg 2010; 210: 957-65.
51. Watson GA, Sperry JL, Rosengart MR, et al. Fresh frozen plasma is independently associated with a higher risk of multiple organ failure and acute respiratory distress syndrome. J Trauma 2009; 67: 221-7; discussion 228.
52. Zander AL, Olson EJ, Van Gent JM, et al. Does resuscitation with plasma increase the risk of venous thromboembolism? J Trauma Acute Care Surg 2015; 78: 39-43; discussion 43.
53. Starkey K, Keene D, Morrison JJ, et al. Impact of high ratios of plasma-to-red cell concentrate on the incidence of acute respiratory distress syndrome in UK transfused combat casualties. Shock 2013; 40: 15-20.
54. Christophe M, Vauthier C, Civadier C, et al. Évaluation des qualité hémostatiques du plasma lyophilisé par mesure de la génération de thrombine. Transfusion Clinique et Biologique 2013; 20: 331-2.
55. Martinaud C, Civadier C, Ausset S, et al. In vitro hemostatic properties of French lyophilized plasma. Anesthesiology 2012; 117: 339-46.
56. Cauet A, Ausset S, Sailliol A. Plasma lyophilisé: données de deux années d’hémovigilance active. Annales Françaises d’Anesthésie et de Réanimation 2014; 33(Suppl 2): A125-6.
57. Sailliol A, Martinaud C, Cap AP, et al. The evolving role of lyophilized plasma in remote damage control resuscitation in the French Armed Forces Health Service. Transfusion 2013; 53(Suppl 1): 65S-71S.
58. ANSM. Agence nationale de sécurité du médicament et des produits de santé. Transfusion de plasma thérapeutique: produits,indications. Recommandations-Argumentaire. ANSM-HAS. 2012 (cited 24 October 2015). http://ansm.sante.fr/Sinformer/ Points-d-information-Points-d-information/Transfusion-de-plasmatherapeutique-Produits-indications-Actualisation-2012-des-recommandations-Point-d-info
59. Martinaud C, Ausset S, Deshayes AV, et al. Use of freeze-dried plasma in French intensive care unit in Afghanistan. J Trauma 2011; 71: 1761-4; discussion 1764.
60. Sailliol A. Plasma in prehospital setting, French experience and data. 4th Remote Damage Control Resuscitation Symposium. 2014 (cited 2 February 2016). http:// rdcr.org/rdcrpresentations/2014-sailliol-plasma-in-prehospital-france.pdf
61. Sunde GA, Vikenes B, Strandenes G, et al. Freeze dried plasma and fresh red blood cells for civilian prehospital hemorrhagic shock resuscitation. J Trauma Acute Care Surg 2015; 78: S26-30.
62. Grottke O, Braunschweig T, Henzler D, et al. Effects of different fibrinogen concentrations on blood loss and coagulation parameters in a pig model of coagulopathy with blunt liver injury. Crit Care 2010; 14: R62.
63. Ranucci M, Baryshnikova E, Crapelli GB, et al. Randomized, double-blinded, placebo-controlled trial of fibrinogen concentrate supplementation after complex cardiac surgery. J Am Heart Assoc 2015; 4: e002066.
64. Aubron C, Reade MC, Fraser JF, et al. Efficacy and safety of fibrinogen concentrate in trauma patients-a systematic review. J Crit Care 2014; 29: 471.e11-17.
65. Maegele M, Zinser M, Schlimp C, et al. Injectable hemostatic adjuncts in trauma: Fibrinogen and the FIinTIC study. J Trauma Acute Care Surg 2015; 78: S76-82.
66. Rossaint R, Bouillon B, Cerny V, et al. The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition. Crit Care 2016; 20: 100.
67. Duranteau J, Asehnoune K, Pierre S, et al. Recommandations sur la réanimation du choc hémorragique. Anesthésie & Réanimation 2015; 1: 62-74.
68. Stinger HK, Spinella PC, Perkins JG, et al. The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. J Trauma 2008; 64: S79-85; discussion S85.
69. Collins PW, Solomon C, Sutor K, et al. Theoretical modelling of fibrinogen supplementation with therapeutic plasma, cryoprecipitate, or fibrinogen concentrate. Br J Anaesth 2014; 113: 585-95.
70. Haute Autorité de Santé. [Good management practices for oral anticoagulant overdose, situations of hemorrhagic risk and hemorrhagic events in patients taking oral anticoagulants in the ambulatory and hospital setting-April 2008]. J Mal Vasc 2008; 33: 202-13.
71. Matsushima K, Benjamin E, Demetriades D. Prothrombin complex concentrate in trauma patients. Am J Surg 2015; 209: 413-7.
72. Joseph B, Amini A, Friese RS, et al. Factor IX complex for the correction of traumatic coagulopathy. J Trauma Acute Care Surg 2012; 72: 828-34.
73. Joseph B, Aziz H, Pandit V, et al. Prothrombin complex concentrate versus fresh-frozen plasma for reversal of coagulopathy of trauma: is there a difference? World J Surg 2014; 38: 1875-81.
74. Schöchl H, Nienaber U, Maegele M, et al. Transfusion in trauma: thromboelastometry-guided coagulation factor concentrate-based therapy versus standard fresh frozen plasma-based therapy. Crit Care 2011; 15: R83.
75. Lendrum RA, Kotze JP, Lockey DJ, et al. Case studies in prehospital care from London HEMS: pre-hospital administration of prothrombin complex concentrate to the head-injured patient. Emerg Med J 2013; 30: 247-8.
76. Gomes JA, Ahrens CL, Hussain MS, et al. Prehospital reversal of warfarin-related coagulopathy in intracerebral hemorrhage in a mobile stroke treatment unit. Stroke 2015; 46: e118-20.
77. Letson HL, Dobson GP. Correction of acute traumatic coagulopathy with small-volume 7.5% NaCl adenosine, lidocaine, and Mg2+ occurs within 5 minutes: a ROTEM analysis. J Trauma Acute Care Surg 2015; 78: 773-83.
78. Letson HL, Dobson GP. Unexpected 100% survival following 60% blood loss using small-volume 7.5% NaCl with adenocaine and Mg(2+) in the rat model of extreme hemorrhagic shock. Shock 2011; 36: 586-94.
79. O’Reilly DJ, Morrison JJ, Jansen JO, et al. Initial UK experience of prehospital blood transfusion in combat casualties. J Trauma Acute Care Surg 2014; 77: S66-70.
80. Watts S, Nordmann G, Brohi K, et al. Evaluation of prehospital blood products to attenuate acute coagulopathy of trauma in a model of severe injury and shock in anesthetized pigs. Shock 2015; 44(Suppl 1): 138-48.
81. O’Reilly DJ, Morrison JJ, Jansen JO, et al. Prehospital blood transfusion in the en route management of severe combat trauma: a matched cohort study. J Trauma Acute Care Surg 2014; 77: S114-20.
82. Boscarino C, Tien H, Acker J, et al. Feasibility and transport of packed red blood cells into Special Forces operational conditions. J Trauma Acute Care Surg 2014; 76: 1013-19.
83. Aye Maung N, Doughty H, MacDonald S, et al. Transfusion support by a UK Role 1 medical team: a 2-year experience from Afghanistan. J R Army Med Corps 2016; 162: 440-4.
84. Spinella PC, Perkins JG, Grathwohl KW, et al. Warm fresh whole blood is independently associated with improved survival for patients with combat-related traumatic injuries. J Trauma 2009; 66: S69-76.
85. Nessen SC, Eastridge BJ, Cronk D, et al. Fresh whole blood use by forward surgical teams in Afghanistan is associated with improved survival compared to component therapy without platelets. Transfusion 2013; 53(Suppl 1): 107S-13S.
86. Esnault P, Cungi PJ, Romanat PE, et al. [Blood transfusion on battlefield. The Kabul hospital experience]. Ann Fr Anesth Reanim 2013; 32: 670-5.
87. Strandenes G, De Pasquale M, Cap AP, et al. Emergency whole-blood use in the field: a simplified protocol for collection and transfusion. Shock 2014; 41 (Suppl 1): 76-83.
88. Strandenes G, Austlid I, Apelseth TO, et al. Coagulation function of stored whole blood is preserved for 14 days in austere conditions: a ROTEM feasibility study during a Norwegian antipiracy mission and comparison to equal ratio reconstituted blood. J Trauma Acute Care Surg 2015; 78: S31-8.
89. Strandenes G, Cap AP, Cacic D, et al. Blood Far Forward-a whole blood research and training program for austere environments. Transfusion 2013; 53(Suppl 1): 124S-30S.
90. Beckett A, Callum J, da Luz LT, et al. Fresh whole blood transfusion capability for Special Operations Forces. Can J Surg 2015; 58: S153-6.
91. Parker P, Nordmann G, Doughty H. Taking transfusion forward. J R Army Med Corps 2015; 161: 2-4.
92. Bowling F, Pennardt A. The use of fresh whole blood transfusions by the SOF medic for hemostatic resuscitation in the austere environment. J Spec Oper Med 2010; 10: 25-35.
93. Strandenes G, Skogrand H, Spinella PC, et al. Donor performance of combat readiness skills of special forces soldiers are maintained immediately after whole blood donation: a study to support the development of a prehospital fresh whole blood transfusion program. Transfusion 2013; 53: 526-30.
94. Cordova CB, Cap AP, Spinella PC. Fresh whole blood transfusion for a combat casualty in austere combat environment. J Spec Oper Med 2014; 14: 9-12.
95. Malsby R, Frizzi J, Ray P, et al. Walking donor transfusion in a far forward environment. South Med J 2005; 98: 809-10.
96. Weaver AE, Hunter-Dunn C, Lyon RM, et al. The effectiveness of a ‘Code Red’ transfusion request policy initiated by pre-hospital physicians. Injury 2016; 47: 3-6.
97. Guyette F, Suffoletto B, Castillo JL, et al. Prehospital serum lactate as a predictor of outcomes in trauma patients: a retrospective observational study. J Trauma 2011; 70: 782-6.
98. Davis JW, Shackford SR, Mackersie RC, et al. Base deficit as a guide to volume resuscitation. J Trauma 1988; 28: 1464-7.
99. Mutschler M, Nienaber U, Brockamp T, et al. Renaissance of base deficit for the initial assessment of trauma patients: a base deficit-based classification for hypovolemic shock developed on data from 16,305 patients derived from the TraumaRegister DGU®. Crit Care 2013; 17: R42.
100. Veldhoen ES, de Vooght KM, Slieker MG, et al. Analysis of bloodgas, electrolytes and glucose from intraosseous samples using an i-STAT(®) point-of-care analyser. Resuscitation 2014; 85: 359-63.
101. Papadea C, Foster J, Grant S, et al. Evaluation of the i-STAT Portable Clinical Analyzer for point-of-care blood testing in the intensive care units of a university children’s hospital. Ann Clin Lab Sci 2002; 32: 231-43.
102. Joslin J, Mularella J, Schreffler S, et al. Novel method for reducing temperature of i-STAT1 analyzer in extreme environments. Wilderness Environ Med 2014; 25: 357-8.
103. Radler D, Wetschler M, Christensen M, et al. Improvised method for increasing the temperature of an i-STAT analyzer and cartridge in cold environments. Wilderness Environ Med 2015; 26: 280-2.
104. Schreiber MA, Perkins J, Kiraly L, et al. Early predictors of massive transfusion in combat casualties. J Am Coll Surg 2007; 205: 541-5.
105. Callcut RA, Johannigman JA, Kadon KS, et al. All massive transfusion criteria are not created equal: defining the predictive value of individual transfusion triggers to better determine who benefits from blood. J Trauma 2011; 70: 794-801.
106. Callcut RA, Cotton BA, Muskat P, et al. Defining when to initiate massive transfusion: a validation study of individual massive transfusion triggers in PROMMTT patients. J Trauma Acute Care Surg 2013; 74: 59-65, 67.
107. Peltan ID, Vande Vusse LK, Maier RV, et al. An international normalized ratio-based definition of acute traumatic coagulopathy is associated with mortality, venous thromboembolism, and multiple organ failure after injury. Crit Care Med 2015; 43: 1429-38.
108. Garcia-Alamino JM, Ward AM, Alonso-Coello P, et al. Self-monitoring and self-management of oral anticoagulation. Cochrane Database Syst Rev 2010;(4): CD003839.
109. Heneghan C, Ward A, Perera R, et al. Self-monitoring of oral anticoagulation: systematic review and meta-analysis of individual patient data. Lancet 2012; 379: 322-34.
110. Mitra B, O’Reilly G, Collecutt M, et al. Prospective comparison of point-of-care international normalised ratio measurement versus plasma international normalised ratio for acute traumatic coagulopathy. Emerg Med Australas 2012; 24: 363-8.
111. David JS, Levrat A, Inaba K, et al. Utility of a point-of-care device for rapid determination of prothrombin time in trauma patients: a preliminary study. J Trauma Acute Care Surg 2012; 72: 703-7.
112. Cotte J, D’Aanda E, Chauvin V, et al. Point-of-care coagulation testing for trauma patients in a military setting: a prospective study. J Spec Oper Med 2013; 13: 59-62.
113. Goodman MD, Makley AT, Hanseman DJ, et al. All the bang without the bucks: defining essential point-of-care testing for traumatic coagulopathy. J Trauma Acute Care Surg 2015; 79: 117-24.
114. Beynon C, Erk AG, Potzy A, et al. Point of care coagulometry in prehospital emergency care: an observational study. Scand J Trauma Resusc Emerg Med 2015; 23: 58.
115. Ausset S, Glassberg E, Nadler R, et al. Tranexamic acid as part of remote damage-control resuscitation in the prehospital setting: a critical appraisal of the medical literature and available alternatives. J Trauma Acute Care Surg 2015; 78: S70-5.
116. David JS, Spann C, Marcotte G, et al. Haemorrhagic shock, therapeutic management. Ann Fr Anesth Reanim 2013; 32: 497-503.
117. Handy JM, Soni N. Physiological effects of hyperchloraemia and acidosis. Br J Anaesth 2008; 101: 141-50.
118. Maegele M, Lefering R, Yucel N, et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 2007; 38: 298-304.
119. Ley EJ, Clond MA, Srour MK, et al. Emergency department crystalloid resuscitation of 1.5 L or more is associated with increased mortality in elderly and nonelderly trauma patients. J Trauma 2011; 70: 398-400.
120. Plurad DS, Talving P, Lam L, et al. Early vasopressor use in critical injury is associated with mortality independent from volume status. J Trauma 2011; 71: 565-70; discussion 570.
121. Sperry JL, Minei JP, Frankel HL, et al. Early use of vasopressors after injury: caution before constriction. J Trauma 2008; 64: 9-14.